The radioactive noble gas radon has anti-inflammatory therapeutic effects but also contains risks. Radon and especially its short-lived progeny are considered to be responsible for about half of the annual radiation exposure ...
Dec 15, 2022
0
1
A new study led by Western Sydney University has shed new light on the treatment of Alzheimer's disease, after researchers identified proteins causing neuronal allergy in neurons treated with Alzheimer therapeutic antibodies.
Dec 15, 2022
0
26
Human beings can sometimes experience dissociative states, moments in which they feel disconnected from their body and the world around them. While these states have been linked to many psychiatric conditions, they can also ...
To prevent testing on animals and create even more precise ways of testing therapeutics, the pharmaceutical industry is increasingly turning to human immune cells. However, the availability of cells like these has been limited ...
Dec 1, 2022
0
2
A KAIST research team led by Ph.D. candidate Jae Hee Lee and Professor Keon Jae Lee from the Department of Materials Science and Engineering has developed a surface-lighting microLED patch for UV-induced melanogenesis inhibition. ...
Nov 23, 2022
0
2
Findings from a new study published in Cell Reports, involving a collaborative effort between researchers at the Luikart Laboratory at Dartmouth's Geisel School of Medicine and the Weston Laboratory at the University of Vermont, ...
Nov 1, 2022
0
784
Researchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in a phase I clinical trial. Until now, no other drug has been able to do this safely and effectively.
Oct 26, 2022
0
10
Every year around 2 million people die worldwide from hemorrhaging or blood loss. Uncontrolled hemorrhaging accounts for more than 30% of trauma deaths. To stop the bleeding, doctors often apply pressure to the wound and ...
Oct 13, 2022
0
4
A paper published in the journal Scientific Reports demonstrates how virtual reality group experiences can produce responses similar to those triggered by psychoactive drugs, such as hallucinogenic mushrooms or LSD.
Sep 14, 2022
0
150
A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.
Sep 7, 2022
0
68
